Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacroli

26 de April de 2022

We are excited to share the newest article on the Protopic® JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study with SIGMA members and collaborators at RTI Health Solutions, PHARMO Institute for Drug Outcomes Research, Syddansk Universitet - University of Southern Denmark and Karolinska Institutet among other coauthors.

The study acronym JOELLE was chosen to honor Dr. Joelle Erkens, pharmacoepidemiologist at Astellas and formerly at PHARMO Institute, who was lost to the research team in June 2011 upon her untimely death.

https://www.dovepress.com/long-term-risk-of-skin-cancer-and-lymphoma-in-users-of-topical-tacroli-peer-reviewed-fulltext-article-CLEP